The Adenosine deaminase deficiency results into
Correct Answer :
Solution :
Correct Answer: The provided option in the data points to "The Adenosine deaminase deficiency results into", which represents Severe Combined Immunodeficiency (SCID).
Explanation:
1. Role of Adenosine Deaminase (ADA):
Adenosine deaminase is a vital enzyme involved in purine metabolism. It works to convert adenosine to inosine and 2'-deoxyadenosine to 2'-deoxyinosine. This enzymatic activity is critical for maintaining healthy lymphocyte function and breaking down potentially toxic metabolites.
2. Consequences of Deficiency:
When a person suffers from Adenosine Deaminase (ADA) deficiency, toxic levels of deoxyadenosine and dATP (deoxyadenosine triphosphate) accumulate in tissues, particularly affecting T and B lymphocytes. High concentrations of dATP inhibit ribonucleotide reductase, an essential enzyme for DNA synthesis and cell proliferation.
3. Clinical Manifestation:
As a result of lymphocyte destruction and dysfunction, affected individuals experience a complete breakdown of both humoral (B cell) and cellular (T cell) immune responses. This condition is medically classified as Severe Combined Immunodeficiency (SCID). Without treatment (such as gene therapy, enzyme replacement, or bone marrow transplantation), individuals with ADA deficiency are severely immunocompromised and highly vulnerable to recurrent severe infections.
4. Reviewing Other Options:
• Parkinson's disease: A neurodegenerative disorder caused by the loss of dopamine-producing neurons in the brain, unrelated to ADA deficiency.
• Digestive disorder: Broad category of gastrointestinal illnesses not specifically or primarily caused by ADA gene mutations.
• Addison's disease: An endocrine disorder characterized by adrenal insufficiency, primarily affecting hormone production rather than purine metabolism in immune cells.
Access expert-curated educational resources and study materials—completely free.
Create, conduct, and manage professional online assessments with Crey. Perfect for teachers and institutes.
Copyright © 2026 Crey. All Rights Reserved.